We are live on ! Find out more
IRD

Opus Genetics
IRD

23 hedge funds and large institutions have $10.2M invested in Opus Genetics in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

39% more capital invested

Capital invested by funds: $7.3M → $10.2M (+$2.88M)

30% less funds holding

Funds holding: 33 → 23 (-10)

56% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 18

Holders
23
Holders Change
-10
Holders Change %
-30.3%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
1
Closed
18
Calls
$86K
Puts
–
Net Calls
+$86K
Net Calls Change
+$86K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.11M
2
AFM
Anson Funds Management
Texas
+$2.12M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.29M
4
SM
Sabby Management
Florida
+$1M
5
BlackRock
BlackRock
New York
+$493K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$286K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$86K
3
BMC
Benin Management Corp
Connecticut
-$63K
4
GC
Guggenheim Capital
Illinois
-$42K
5
Citadel Advisors
Citadel Advisors
Florida
-$40K

IRD Hedge Fund Activity: Q2 2017 in Review

23 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q2 2017, worth a combined $10.2M — up 39% from $7.3M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of IRD and 8 opened new positions — a net loss of 10 holders — while 1 trimmed existing stakes and 7 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $4.11M. The largest seller was Renaissance Technologies, cutting an estimated $286K.

  • 23 institutional investors held Opus Genetics (IRD) as of Q2 2017, down from 33 in Q1 2017.
  • Funds reported $10.2M of Opus Genetics stock for Q2 2017, up 39% quarter-over-quarter.
  • 8 funds opened new Opus Genetics positions in Q2 2017 and 18 closed out, a net change of -10 holders.
  • The largest Opus Genetics buyer in Q2 2017 was Susquehanna International Group, an estimated $4.11M added.
  • The largest Opus Genetics seller in Q2 2017 was Renaissance Technologies, an estimated $286K sold.

Based on aggregated 13F filings for Q2 2017.